참고문헌
- Nogales-Gadea G, Santalla A, Brull A, de Luna N, Lucia A, Pinos T. The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications. J Inherit Metab Dis 2015;38:221-30. https://doi.org/10.1007/s10545-014-9743-2
- Lebo RV, Gorin F, Fletterick RJ, Kao FT, Cheung MC, Bruce BD, et al. High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11. Science 1984;225:57-9. https://doi.org/10.1126/science.6587566
- Sohn EH, Kim HS, Lee AY, Fukuda T, Sugie H, Kim DS. A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay. Neuromuscul Disord 2008;18:886-9. https://doi.org/10.1016/j.nmd.2008.06.384
- Tsujino S, Shanske S, DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (Mc- Ardle's disease). N Engl J Med 1993;329:241-5. https://doi.org/10.1056/NEJM199307223290404
- Rubio JC, Martin MA, Campos Y, Auciello R, Cabello A, Arenas J. A missense mutation W797R in the myophosphorylase gene in a Spanish patient with Mc- Ardle's disease. Muscle Nerve 2000;23:129-31. https://doi.org/10.1002/(SICI)1097-4598(200001)23:1<129::AID-MUS20>3.0.CO;2-F
- Tsujino S, Shanske S, Goto Y, Nonaka I, DiMauro S. Two mutations, one novel and one frequently observed, in Japanese patients with McArdle's disease. Hum Mol Genet 1994;3:1005-6. https://doi.org/10.1093/hmg/3.6.1005
- Tsujino S, Shanske S, Nonaka I, Eto Y, Mendell JR, Fenichel GM, et al. Three new mutations in patients with myophosphorylase deficiency (McArdle disease). Am J Hum Genet 1994;54:44-52. https://doi.org/10.1002/ajmg.1320540109
- Nogales-Gadea G, Brull A, Santalla A, Andreu AL, Arenas J, Martin MA, et al. McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene. Hum Mutat 2015;36:669-78. https://doi.org/10.1002/humu.22806
- Angelini C. State of the art in muscle glycogenoses. Acta Myol 2010;29:339-42.
- Nogales-Gadea G, Arenas J, Andreu AL. Molecular genetics of McArdle's disease. Curr Neurol Neurosci Rep 2007;7:84-92. https://doi.org/10.1007/s11910-007-0026-2
- Wolfe GI, Baker NS, Haller RG, Burns DK, Barohn RJ. McArdle's disease presenting with asymmetric, late-onset arm weakness. Muscle Nerve 2000;23:641-5. https://doi.org/10.1002/(SICI)1097-4598(200004)23:4<641::AID-MUS25>3.0.CO;2-M
- Nogales-Gadea G, Godfrey R, Santalla A, Coll-Canti J, Pintos-Morell G, Pinos T, et al. Genes and exercise intolerance: insights from McArdle disease. Physiol Genomics 2016;48:93-100. https://doi.org/10.1152/physiolgenomics.00076.2015
- Braakhekke JP, de Bruin MI, Stegeman DF, Wevers RA, Binkhorst RA, Joosten EM. The second wind phenomenon in McArdle's disease. Brain 1986;109(Pt 6):1087-101. https://doi.org/10.1093/brain/109.6.1087
- Vissing J, Haller RG. A diagnostic cycle test for McArdle's disease. Ann Neurol 2003;54:539-42. https://doi.org/10.1002/ana.10725
- Shin JH, Kim DG, Shin JY, Lee SHPW. A Case of Adult Onset Glycogen Storage Myopathy. Korean J Clin Neurophysiol 2014;16:81-5. https://doi.org/10.14253/kjcn.2014.16.2.81
- Lee SI, Song CW, Park KH, Kim SW. A Case of McArdle's Disease. J Korean neurol Assoc 1992;10:554-8.
- Park HJ, Shin HY, Cho YN, Kim SM, Choi YC. The significance of clinical and laboratory features in the diagnosis of glycogen storage disease type v: a case report. J Korean Med Sci 2014;29:1021-4. https://doi.org/10.3346/jkms.2014.29.7.1021
- Sugie H, Sugie Y, Ito M, Fukuda T, Nonaka I, Igarashi Y. Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation. Clin Chim Acta 1995;236:81-6. https://doi.org/10.1016/0009-8981(95)06044-X
- Andreu AL, Nogales-Gadea G, Cassandrini D, Arenas J, Bruno C. McArdle disease: molecular genetic update. Acta Myol 2007;26:53-7.
- Lucia A, Ruiz JR, Santalla A, Nogales-Gadea G, Rubio JC, Garcia-Consuegra I, et al. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry 2012;83:322-8. https://doi.org/10.1136/jnnp-2011-301593
- Quinlivan R, Martinuzzi A, Schoser B. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Cochrane Database Syst Rev 2014;11:Cd003458.
- MacLean D, Vissing J, Vissing SF, Haller RG. Oral branched-chain amino acids do not improve exercise capacity in McArdle disease. Neurology 1998;51:1456-9. https://doi.org/10.1212/WNL.51.5.1456
- Day TJ, Mastaglia FL. Depot-glucagon in the treatment of McArdle's disease. Aust N Z J Med 1985;15:748-50.
- Steele IC, Patterson VH, Nicholls DP. A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease. J Neurol Sci 1996;136:174-7. https://doi.org/10.1016/0022-510X(95)00320-2
- Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, et al. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol 2000;57:956-63. https://doi.org/10.1001/archneur.57.7.956
- Phoenix J, Hopkins P, Bartram C, Beynon RJ, Quinlivan RC, Edwards RH. Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study. Neuromuscul Disord 1998;8:210-2. https://doi.org/10.1016/S0960-8966(98)00004-2
- Quinlivan R, Vissing J, Hilton-Jones D, Buckley J. Physical training for McArdle disease. Cochrane Database Syst Rev 2011:Cd007931.
- Mate-Munoz JL, Moran M, Perez M, Chamorro- Vina C, Gomez-Gallego F, Santiago C, et al. Favorable responses to acute and chronic exercise in Mc- Ardle patients. Clin J Sport Med 2007;17:297-303. https://doi.org/10.1097/JSM.0b013e3180f6168c
- Garcia-Benitez S, Fleck SJ, Naclerio F, Martin MA, Lucia A. Resistance (weight lifting) training in an adolescent with McArdle disease. J Child Neurol 2013;28:805-8. https://doi.org/10.1177/0883073812451328
- Dasouki M, Jawdat O, Almadhoun O, Pasnoor M, McVey AL, Abuzinadah A, et al. Pompe disease: literature review and case series. Neurol Clin 2014;32:751-76, ix. https://doi.org/10.1016/j.ncl.2014.04.010